The Effectiveness of Non-Pyrethroid Insecticide-Treated Durable Wall Liners as a Method for Malaria Control in Endemic Rural Tanzania
NCT02533336 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 4917
Last updated 2019-02-05
Summary
Over one year period in an area with universal coverage of LLIN and ACT provision as the first-line treatment of malaria, the investigators intend to evaluate the impact of DL on malaria transmission as measured by the incidence of malaria parasitemia, the prevalence of moderate to severe anemia, and entomological parameters. Information on the relative cost-effectiveness estimates of DL and the community acceptability of DL will also be measured.
Conditions
Interventions
- DRUG
-
abamectin and fenpyroximate
Sponsors & Collaborators
-
Kilimanjaro Christian Medical Centre, Tanzania
collaborator OTHER -
London School of Hygiene and Tropical Medicine
collaborator OTHER -
Centers for Disease Control and Prevention
collaborator FED -
Brandeis University
collaborator OTHER -
United States Agency for International Development (USAID)
collaborator FED -
National Institute for Medical Research, Tanzania
lead OTHER_GOV
Principal Investigators
-
William N Kisinza, PhD · National Institute for Medical Research
-
Joseph P Mugasa, PhD · National Institute for Medical Research
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 6 Months
- Max Age
- 11 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-11-09
- Primary Completion
- 2016-08-31
- Completion
- 2017-03-31
Countries
- Tanzania
Study Locations
More Related Trials
-
Sanaria PfSPZ Challenge With Pyrimethamine Chemoprophylaxis (PfSPZ-CVac Approach): Phase 1 Trial to Determine Safety and Protective Efficacy of Sanaria PfSPZ Challenge With Concurrent Pyrimethamine Treatment That Inhibits Development of Asexual B...
NCT02511054 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Immunogenicity, and Protective Efficacy of Radiation Attenuated Plasmodium Falciparum NF54 Sporozoites in Healthy African Adults in Mali
NCT02627456 ·Status: COMPLETED ·Phase: PHASE1
-
Pan-Malaria Transmission-Blocking Vaccine AnAPN1
NCT05905432 ·Status: COMPLETED ·Phase: PHASE1
-
Study of the Safety and Immunogenicity of Pfs230D1M-EPA/Alhydrogel and Pfs25M-EPA/Alhydrogel , a Transmission Blocking Vaccine Against Plasmodium Falciparum Malaria, in Adults in the U.S. and Mali
NCT02334462 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Safety and Effectiveness of Intravenous Immunization With PfSPZ Vaccine in Healthy African Adults
NCT01988636 ·Status: COMPLETED ·Phase: PHASE1
-
Sanaria PfSPZ Challenge With Pyrimethamine or Chloroquine Chemoprophylaxis Vaccination (PfSPZ-CVac Approach): A Randomized Double Blind Placebo Controlled Phase I/II Trial to Determine Safety and Protective Efficacy Against Natural Plasmodium Falcipa...
NCT03952650 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety, Immunogenicity and ex Vivo Efficacy of Pfs25-IMX313/Matrix-M in Healthy Volunteers in Bagamoyo, Tanzania.
NCT04271306 ·Status: TERMINATED ·Phase: PHASE1
-
Controlled Human Malarial Infection by Intravenous Injection of Plasmodium Falciparum Sporozoites in Non-Immune Adults
NCT01624961 ·Status: COMPLETED ·Phase: PHASE1
-
Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria
NCT07235020 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Determine if New Types of Malaria Vaccines Are Safe, Effective and Lead to Immunity in Kenyan Adults
NCT03947190 ·Status: TERMINATED ·Phase: PHASE2
-
Estivation of Malaria Vector Mosquitoes in the Sahelian Region of Mali
NCT00863408 ·Status: COMPLETED
-
Dose Escalation, Randomized Controlled Trial to Evaluate the Safety, Immunogenicity and Efficacy of Intravenously Administered Attenuated Plasmodium Falciparum Sporozoite Vaccine (PfSPZ Vaccine) in Tanzanian Adults
NCT02132299 ·Status: COMPLETED ·Phase: PHASE1
-
Malaria Infection Diagnosed by Polymerase Chain Reaction (PCR) as a Means of Evaluating Pre-erythrocytic Candidate Malaria Vaccines
NCT00121823 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
PfSPZ Challenge in Healthy Malaria-Naïve Adults in the United States
NCT02773979 ·Status: COMPLETED ·Phase: PHASE1
-
Anti-malaria MAb in Kenyan Children
NCT05400655 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Sanaria's PfSPZ-CVac in Malian Adults
NCT02996695 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess Efficacy of New Malaria Vaccine Candidates AdCh63 AMA1, MVA AMA1, AdCh63 MSP1, MVA MSP1, AdCh63 ME-TRAP & MVA ME-TRAP
NCT01142765 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Open-Label Study to Assess Meplazumab in Adult Patients Diagnosed with Plasmodium Falciparum
NCT06040346 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Clinical Trial to Assess the Safety and Immunogenicity of New Malaria Vaccine Candidates ChAd63 Pfs25-IMX313 and MVA Pfs25-IMX313
NCT02532049 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Immunogenicity, and Protective Efficacy of Radiation Attenuated Plasmodium Falciparum NF54 Sporozoites (PfSPZ Vaccine) During Malaria Transmission Season in Healthy African Adult Women of Childbearing Potential in Mali
NCT03989102 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Protective Efficacy of Genetically Attenuated PfSPZ-GA1 Vaccine in Healthy Dutch Volunteers
NCT03163121 ·Status: COMPLETED ·Phase: PHASE1
-
Pfs230D1M-EPA/AS01 Vaccine, a Transmission Blocking Vaccine Against Plasmodium Falciparum, in an Age De-Escalation Trial of Children and a Family Compound Trial in Mali
NCT03917654 ·Status: COMPLETED ·Phase: PHASE2
-
Immunization With Different Doses of Plasmodium Falciparum Sporozoites Under Chloroquine Prophylaxis
NCT01218893 ·Status: COMPLETED ·Phase: NA
-
Safety and Causal Prophylactic Efficacy of KAF156 in a Controlled Human Malaria Challenge Model
NCT04072302 ·Status: COMPLETED ·Phase: PHASE1
-
Experimental Human Malaria Infection by PfSPZ
NCT01086917 ·Status: COMPLETED ·Phase: PHASE1